The American College of Radiology board of selected three innovators as 2017 Gold Medalists for their extraordinary service to the college or radiology. Honors will be presented bestowed during ACR 2017 – The Crossroads of Radiology meeting in Washington May 21-25, 2017. The following individuals will receive the ACR Gold Medal: Bruce Hillman, of Wake […]
THE ROYAL NETHERLANDS Academy of Arts and Sciences named cancer researcher Bert Vogelstein as the very first recipient of the KNAW Bob Pinedo Cancer Care Award. In the 1980s, Vogelstein demonstrated the genetic mechanism that leads to cancer. He is now working on cancer therapies that utilize the patient’s immune system. He is also developing […]
MILTON BROWN was named director of the new Inova Center for Drug Discovery and Development and as deputy director for drug discovery for the Inova Schar Cancer Institute. Brown is one of a handful of physician scientists in the United States who hold a Ph.D. in synthetic chemistry and an M.D. He will bring his […]
JOSHUA COLEMAN was named vice president of medical affairs at GenomOncology. He will oversee clinical content development and curation of scientific evidence, enhancing the company’s proprietary knowledge-enabled platform. The GenomOncology software suite empowers molecular pathologists with a seamless workflow for the interpretation of genetic sequencing data and clinical decision support, from quality control through reporting. […]
TEMPUS, a technology company focused on supporting physicians delivering customized cancer care, and the University of Pennsylvania Abramson Cancer Center partnered to better determine which patients will have a positive response to immunotherapy treatment based on next generation genomic and transcriptomic sequencing. As part of a research collaboration, Tempus will provide sequencing and analysis of […]
AMGEN and Allergan plc submitted a Marketing Authorization Application to the European Medicines Agency for ABP 215, a biosimilar candidate to Avastin (bevacizumab). The companies said they this submission is the first bevacizumab biosimilar application submitted to the EMA. ABP 215 is a biosimilar candidate to bevacizumab, a recombinant immunoglobulin G1 monoclonal antibody that binds […]
ABBVIE said the European Commission granted conditional marketing authorization for Venclyxto (venetoclax) monotherapy for the treatment of chronic lymphocytic leukaemia in the presence of 17p deletion or TP53 mutation in adult patients who are unsuitable for or have failed a B-cell receptor pathway inhibitor; and for the treatment of CLL in the absence of 17p […]
MICHAEL ZINNER was elected chair of the Board of Regents of the American College of Surgeons. Zinner is a general surgeon with expertise in pancreatic-hepatobiliary diseases. Since 2016, he has been the founding chief executive officer and executive medical director of the Miami Cancer Institute–Baptist Health South Florida. Prior to that time, he served as […]
Donald S. Coffey, Ph.D., cancer warrior, humanist, mentor to hundreds of researchers and physicians, friend to countless people, was filled with a burning curiosity to understand the world and to know personally everyone he came in contact with.
Dr. Oliver "Ollie" Press, photographed on Jan. 19, 2017 at the Fred Hutchinson Cancer Research Center in Seattle, Washington.Oliver “Ollie” Press, a blood cancer physician who made foundational contributions to the development of targeted cancer therapies, died Sept. 29 of complications from glioma. He was 65.
